These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3883589)

  • 21. Effect of panel-reactive antibody in predicting crossmatch selection of cadaveric kidney recipients.
    Lieber SR; Perez FV; Tabossi MR; Persoli LB; Marques SB; Mazzali M; Alves-Filho G; de Souza CA
    Transplant Proc; 2007 Mar; 39(2):429-31. PubMed ID: 17362748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dominant effect of transfusions on kidney graft survival.
    Opelz G; Terasaki PI
    Transplantation; 1980 Feb; 29(2):153-8. PubMed ID: 6986688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of positive crossmatch against donor B lymphocytes in kidney transplantation: a prospective one-center study.
    Hourmant M; Bignon JD; Cesbron A; Soulillou JP
    Clin Transpl; 1990; ():301-9. PubMed ID: 2103154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitization and crossmatching in renal transplantation.
    Koka P; Cecka JM
    Clin Transpl; 1989; ():379-90. PubMed ID: 2487606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of early kidney transplant rejection by a crossmatch with donor skin.
    Moraes JR; Pettaway C; Stastny P
    Transplantation; 1989 Dec; 48(6):951-2. PubMed ID: 2688207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly Sensitized Patients: Miami Transplant Institute Experience.
    Mattiazzi AD; Centeno A; Amador A; Fernandez-Bango C; Scowby CD; O'Rourke M; Hill-Matthie T; Patel R; Barrios F; Ruiz P; Chen L; Saghesima J; Ciancio G; Burke GW; Goldstein M; Chandar J; Contreras G; Roth D; Kupin W; Guerra G; Vianna R
    Clin Transpl; 2014; ():171-8. PubMed ID: 26281142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacy.
    Salvatierra O; Melzer J; Potter D; Garovoy M; Vincenti F; Amend WJ; Husing R; Hopper S; Feduska NJ
    Transplantation; 1985 Dec; 40(6):654-9. PubMed ID: 3907038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
    Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peri-operative alemtuzumab (Campath-1H) and plasmapheresis for high-PRA positive lymphocyte crossmatch heart transplant: a strategy to shorten left ventricular assist device support.
    Lick SD; Vaidya S; Kollar AC; Boor PJ; Vertrees RA
    J Heart Lung Transplant; 2008 Sep; 27(9):1036-9. PubMed ID: 18765198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Living-donor kidney transplant in T-cell and B-cell flow cytometry crossmatch-positive patients.
    Terasaka S; Kitada H; Okabe Y; Kawanami S; Noguchi H; Miyamoto K; Tsuchimoto A; Masutani K; Tanaka M
    Exp Clin Transplant; 2014 Jun; 12(3):227-32. PubMed ID: 24907723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitization and sensitivity: defining the unsensitized patient.
    Gebel HM; Bray RA
    Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers in transplantation: Prospective, blinded measurement of predictive value for the flow cytometry crossmatch after negative antiglobulin crossmatch in kidney transplantation.
    Wen R; Wu V; Dmitrienko S; Yu A; Balshaw R; Keown PA;
    Kidney Int; 2006 Oct; 70(8):1474-81. PubMed ID: 16941026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment with donor-specific blood transfusions in related recipients with high MLC.
    Salvatierra O; Amend W; Vincenti F; Potter D; Iwaki Y; Opelz G; Terasaki P; Duca R; Hanes D; Cochrum KC; Hopper S; Feduska NJ
    Transplant Proc; 1981 Mar; 13(1 Pt 1):142-9. PubMed ID: 6455788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab in highly sensitized kidney transplant recipients.
    Munoz AS; Rioveros AA; Cabanayan-Casasola CB; Danguilan RA; Ona ET
    Transplant Proc; 2008 Sep; 40(7):2218-21. PubMed ID: 18790197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allografts.
    Gaber AO; Thistlethwaite JR; Haag BW; Stuart JK; Mayes JT; Lloyd DM; Fellner S; Stuart FP
    Am Surg; 1987 Jul; 53(7):407-9. PubMed ID: 3300451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of patients at risk for inferior renal allograft outcome by a strongly positive B cell flow cytometry crossmatch.
    Lazda VA
    Transplantation; 1994 Mar; 57(6):964-9. PubMed ID: 8154047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy.
    Holt DB; Lublin DM; Phelan DL; Boslaugh SE; Gandhi SK; Huddleston CB; Saffitz JE; Canter CE
    J Heart Lung Transplant; 2007 Sep; 26(9):876-82. PubMed ID: 17845925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abrogation of antibodies improves outcome of renal transplantation.
    Trivedi HL; Vanikar AV; Gumber MR; Patel HV; Shah PR; Kute VB
    Transplant Proc; 2012 Jan; 44(1):241-7. PubMed ID: 22310623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.